BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2908240)

  • 1. Antagonization of tetramisole toxicity by hexamethonium.
    Fayez M; Aly F; el-Sawey A
    Chemioterapia; 1987 Jun; 6(2 Suppl):317-9. PubMed ID: 2908240
    [No Abstract]   [Full Text] [Related]  

  • 2. H1-blocker blocks ganglion blocker.
    Tongia SK; Vijayvargiya R; Pande S
    Indian J Physiol Pharmacol; 1982; 26(1):99-100. PubMed ID: 6125475
    [No Abstract]   [Full Text] [Related]  

  • 3. Protection by glucocorticoids against ganglioplegics.
    Selye H
    Res Commun Chem Pathol Pharmacol; 1970 Jul; 1(4):572-9. PubMed ID: 4400176
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of dihydroergotamine on the change in tonus of the cerebral vessels, caused by serotonin].
    Mashkovskiĭ MD; Lanskiĭ VP
    Farmakol Toksikol; 1968; 31(6):671-4. PubMed ID: 4388888
    [No Abstract]   [Full Text] [Related]  

  • 5. The pressor effect of oxotremorine and arecoline in rats.
    Phan DV; György L
    Acta Physiol Acad Sci Hung; 1973; 43(1):71-84. PubMed ID: 4149154
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison between the ganglionic effects of decamethonium and those of eserine. Studies on the mechanism of disinversion of nicotinic acetylcholine after ganglioplegics].
    Hazard R; Boissier JR; Renier E; Renier-Cornec A
    C R Seances Soc Biol Fil; 1970 Sep; 164(2):251-4. PubMed ID: 4394625
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiovascular actions of a new metabolite of propranolol: isopropylamine.
    Ishizaki T; Privitera PJ; Walle T; Gaffney TE
    J Pharmacol Exp Ther; 1974 Jun; 189(3):626-32. PubMed ID: 4152314
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of neurolytic substances on the activity of sulfur-containing radioprotective preparations].
    Strelkov RB
    Radiobiologiia; 1967; 7(6):939-40. PubMed ID: 4391452
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mechanisms of the pressure effect of synthetic angiotensin-2 on arterial pressure].
    Riazhenov VV; Kudrin AN; Babkina TA
    Farmakol Toksikol; 1973; 36(1):36-9. PubMed ID: 4405496
    [No Abstract]   [Full Text] [Related]  

  • 10. A central effect of angiotensin: release of pituitary pressor material.
    Severs WB; Summy-Long J; Taylor JS; Connor JD
    J Pharmacol Exp Ther; 1970 Jul; 174(1):27-34. PubMed ID: 4393201
    [No Abstract]   [Full Text] [Related]  

  • 11. GANGLIONIC ACTIONS OF MUSCARINIC SUBSTANCES.
    JONES A
    J Pharmacol Exp Ther; 1963 Aug; 141():195-205. PubMed ID: 14057913
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of ganglionic substances on the oxygenation of blood and tissue in toxic lung edema].
    Beketov AI
    Farmakol Toksikol; 1969; 32(1):31-3. PubMed ID: 4388896
    [No Abstract]   [Full Text] [Related]  

  • 13. [Change of natriuresis during intravenous administration of benzohexonium].
    Kuz'min OB
    Farmakol Toksikol; 1970; 33(1):37-9. PubMed ID: 4393228
    [No Abstract]   [Full Text] [Related]  

  • 14. [EFFECT OF GANGLIONIC BLOCKADE WITH HEXONIUM AND DICOLINE ON THE SENSITIVITY TO ACUTE BLOOD LOSS].
    DENISOV AT
    Patol Fiziol Eksp Ter; 1964; 8():79-80. PubMed ID: 14312816
    [No Abstract]   [Full Text] [Related]  

  • 15. The bronchoconstrictor action of capsaicin in the guinea pig.
    Molnár J; Makara G; György L; Unyi G
    Acta Physiol Acad Sci Hung; 1969; 36(4):413-20. PubMed ID: 4393241
    [No Abstract]   [Full Text] [Related]  

  • 16. Some pharmacological characteristics of ganglionic activity of lobeline.
    Mansuri SM; Kelkar VV; Jindal MN
    Arzneimittelforschung; 1973 Dec; 23(12):1721-5. PubMed ID: 4150214
    [No Abstract]   [Full Text] [Related]  

  • 17. [Modifying agents of algial hypertension in rabbits].
    Boissier JR; Viars P; Giudicelli JF
    Anesth Analg (Paris); 1970; 27(2):277-90. PubMed ID: 4393042
    [No Abstract]   [Full Text] [Related]  

  • 18. Vasoconstricting effect of vasopressin on regional vascular beds in conscious rats after ganglionic blockade.
    Teranishi Y; Shimamoto Y; Fujii T
    Hiroshima J Med Sci; 1993 Jun; 42(2):83-8. PubMed ID: 7902831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of neuroplegic and ganglion-blocking drugs in the treatment of craniocerebral injuries].
    UGLOV FG; LUCHKO GD
    Vestn Khir Im I I Grek; 1962 Nov; 89():63-9. PubMed ID: 13995220
    [No Abstract]   [Full Text] [Related]  

  • 20. Letter: Unusual ganglionic receptor site for choline in rats.
    Singh GS
    Indian J Physiol Pharmacol; 1974; 18(1):68. PubMed ID: 4414460
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.